Pregnancy at enrollment.
Any condition, which in the opinion of the provider, will seriously compromise the participant's ability to comply with the protocol, including adherence to PrEP medication dosing, such as active, untreated or unstable major mental illness (i.e. untreated psychotic disorder).
Use of prohibited medications, in particular, agents known to be nephrotoxic or drugs slow in renal excretion.
Previous participation in an HIV vaccine trial. Participants that were documented to have received only placebo are not excluded.
Signs or symptoms suspicious for Primary HIV Infection (PHI).

NCT02584140_exc_T1
Condition
Pregnancy
NCT02584140_exc_T2
Temporal
at enrollment
NCT02584140_exc_T3
Reference_point
enrollment
NCT02584140_exc_T5
Qualifier
nephrotoxic
NCT02584140_exc_T6
Procedure
agents
NCT02584140_exc_T7
Procedure
drugs
NCT02584140_exc_T8
Qualifier
slow in renal excretion
NCT02584140_exc_T10
Observation
HIV vaccine trial
NCT02584140_exc_T11
Person
participation
NCT02584140_exc_T12
Temporal
Previous
NCT02584140_exc_T13
Person
Participants
NCT02584140_exc_T14
Procedure
placebo
NCT02584140_exc_T15
Mood
not
NCT02584140_exc_T16
Condition
Primary HIV Infection
NCT02584140_exc_T17
Condition
PHI
NCT02584140_exc_T18
Condition
symptoms
NCT02584140_exc_T19
Condition
Signs
NCT02584140_exc_T20
Scope
Signs or symptoms